| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ERNST & YOUNG, LLP | 10,000 | 5,000 | 0 | 5,000 |
| Description of Property | Date Acquired | Cost or Other Basis | Prior Years' Depreciation | Computation Method | Rate / Life (# of years) |
Current Year's Depreciation Expense | Net Investment Income | Adjusted Net Income | Cost of Goods Sold Not Included |
|---|
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| CLOSING LONG ACCOUNT #8228 | 5,152,171 | 42,904,385 |
| CLOSING LONG ACCOUNT #2219 | 5,326,083 | 9,872,280 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| TIGER GLOBAL PRIVATE INVEST | AT COST | 2,208,183 | 2,208,183 |
| BIOPHARMA CREDIT INVESTMENT V | AT COST | 2,045,898 | 2,045,898 |
| KENSICO OFFSHORE FUND II | AT COST | 646,352 | 646,352 |
| GOLUB CAPITAL LLC | AT COST | 1,000,000 | 1,000,000 |
| Description | Amount |
|---|---|
| EXCESS OF FMV OVER FOUNDATION'S COST | 0 |
| BASIS OF SECURITIES RECEIVED | 2,824,367 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INVESTMENT EXPENSE | 72,197 | 72,197 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| BIOPHARMA CREDIT INVESTMENTS V LP | 8,936 | 8,936 | 0 |
| TIGER GLOBAL PRIVATE INVESTMENT | 1 | 1 | 0 |
| Description | Amount |
|---|---|
| EXCESS OF FMV OVER FOUNDATION'S COST | 0 |
| BASIS OF SECURITIES DONATED TO | 0 |
| QUALIFYING CHARITY | 2,813,683 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| MANAGEMENT FEES | 78,846 | 78,846 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FEDERAL TAX | 40,000 |